Exact Mass: 424.16930179999997
Exact Mass Matches: 424.16930179999997
Found 500 metabolites which its exact mass value is equals to given mass value 424.16930179999997,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Clindamycin
C18H33ClN2O5S (424.17985980000003)
Clindamycin is a semisynthetic lincosamide antibiotic that has largely replaced lincomycin due to an improved side effect profile. Clindamycin inhibits bacterial protein synthesis by binding to bacterial 50S ribosomal subunits. It may be bacteriostatic or bactericidal depending on the organism and drug concentration. Clindamycin, also known as cleocin or 7-CDL, belongs to the class of organic compounds known as proline and derivatives. Proline and derivatives are compounds containing proline or a derivative thereof resulting from reaction of proline at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. Clindamycin is a drug. Clindamycin is a semisynthetic lincosamide antibiotic that has largely replaced lincomycin due to an improved side effect profile. Clindamycin is a very strong basic compound (based on its pKa). In humans, clindamycin is involved in clindamycin action pathway. Orally and parenterally administered clindamycin has been associated with severe colitis (pseudomembranous colitis) which may result in patient death. Use of the topical formulation of clindamycin results in absorption of the antibiotic from the skin surface. Clindamycin is a potentially toxic compound. Rapidly absorbed after oral administration with peak serum concentrations observed after about 45 minutes. Oral; topical; parenteral (intramuscular, intravenous). Systemic/vaginal clindamycin inhibits protein synthesis of bacteria by binding to the 50S ribosomal subunits of the bacteria. Clindamycin. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=18323-44-9 (retrieved 2024-06-28) (CAS RN: 18323-44-9). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
N,N'-diacetylchitobiose
C16H28N2O11 (424.16930179999997)
N,N-diacetylchitobiose, also known as (GlcNAc)2, is classified as a member of the Acylaminosugars. Acylaminosugars are organic compounds containing a sugar linked to a chain through N-acyl group. N,N-diacetylchitobiose is considered to be soluble (in water) and acidic. N,N-diacetylchitobiose may be a unique E.coli metabolite N,N'-Diacetylchitobiose is a dimer of β(1,4) linked N-acetyl-D glucosamine. N,N'-Diacetylchitobiose is the hydrolysate of chitin and can be used as alternative carbon source by?E. coli[1].
Trimethobenzamide hydrochloride
C21H29ClN2O5 (424.17648940000004)
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents Trimethobenzamide hydrochloride is a blocker of the D2 receptor. Trimethobenzamide is an antiemetic used to prevent nausea and vomiting.
Taraxinic acid glucosyl ester
Constituent of Taraxacum officinale (dandelion). Taraxinic acid glucosyl ester is found in many foods, some of which are coffee and coffee products, dandelion, tea, and alcoholic beverages. Taraxinic acid glucosyl ester is found in alcoholic beverages. Taraxinic acid glucosyl ester is a constituent of Taraxacum officinale (dandelion).
D-Cloprostenol
C22H29ClO6 (424.16525640000003)
8-Acetylneosolaniol
Calix[4]arene
Methanone, ((2R,5R)-5-(((5-fluoro-2-pyridinyl)oxy)methyl)-2-methyl-1-piperidinyl)(5-fluoro-2-(2-pyrimidinyl)phenyl)-
Forsmann antigen
C16H28N2O11 (424.16930179999997)
Galnac-1-4-glcnac
C16H28N2O11 (424.16930179999997)
Lacdinac
C16H28N2O11 (424.16930179999997)
N,N'-Diacetylchitobiose is a dimer of β(1,4) linked N-acetyl-D glucosamine. N,N'-Diacetylchitobiose is the hydrolysate of chitin and can be used as alternative carbon source by?E. coli[1].
SPIRADOLINE
C22H30Cl2N2O2 (424.16842199999996)
Crepidiaside B
Crepidiaside b is a member of the class of compounds known as O-glycosyl compounds. O-glycosyl compounds are glycoside in which a sugar group is bonded through one carbon to another group via a O-glycosidic bond. Crepidiaside b is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Crepidiaside b can be found in chicory and endive, which makes crepidiaside b a potential biomarker for the consumption of these food products.
[3aR-(3aR*,5E,9Z,11aR*)]- 2,3,3a,4,7,8,11,11a-Octahydro-6-methyl-3-methylene-2-oxo-, beta-D-glucopyranosyl ester cyclodeca[b]furan-10-carboxylic acid
methyl 2-((2,2-dimethylchroman-6-yl)methyl)-4-hydroxy-3-(4-hydroxyphenyl)-5-oxo-2,5-dihydrofuran-2-carboxylate
16-Acetoxy-15-bromo-7-hydroxy-9(11)-parguerene
C22H33BrO3 (424.16129280000007)
[4R-(4R*,5S*,6S*,7S*,10R*,11E)]- 3-[(Acetyloxy)methyl]-5,6,7,8,9,10-hexahydro-6,7-dihydroxy-5,6,10-trimethyl-4-(1-oxopropoxy)-7,10-epoxycyclodeca[b]furan-2(4H)-one
9-(3-Hydroxy-3-methylglutaroyloxy)-abscisic acid|beta-hydroxy-beta-methylglutarylhydroxyabscisic acid
15-glucopyranosyloxy-2-oxo-guaia-3,11(13)-dien-1beta,5alpha,6beta,7alpha,10alphaH-12,6-olide
15-bromoparguer-9(11)-ene-2,16-diol 2-acetate
C22H33BrO3 (424.16129280000007)
11,13alpha-dihydroixerin Z|11beta,13-dihydroixerin Z
11beta-hydroxyleucodin 11-O-beta-D-glucopyranoside|11beta-hydroxyleucodin-11-O-beta-glucopyranoside|11beta-hydroxyleucodin-O-beta-D-glucopyranoside|11beta-hydroxyleukodin 11-O-beta-glucopyranoside|11??-Hydroxyleukodin 11-O-??-glucopyranoside
beta-hydroxy-beta-methylglutaryl ester of 8-hydroxyabscisic acid
10,11-dioxo-aspidofractinine-1,3-dicarboxylic acid dimethyl ester|10,11-Dioxo-pleiocarpin
8beta,9alpha-dihydroxy-5alpha,9betaH-lindan-4(15),7(13)-dien-8alpha,12-olide-8beta-O-beta-D-glucopyranoside|chloranthalactone E 8-O-beta-D-glucopyranoside
2-hydroxy-4-[4-hydroxyphenyl-(4-hydroxy-3-methoxybenzyl)]-3-(3,5-dihydroxyphenyl)tetrahydrofuran|pouzolignan A
3alpha-acetoxy-5beta-(4-acetoxytigloyloxy)-7-acetoxycarvotanacetone
2,4,5,5-tetramethoxy-2,2-dimethylpyrano<6,5-h>isoflavone|2,4,5,5-Tetramethoxy-2,2-dimethylpyrano-<6,5-h>isoflavone|5-Methoxy-8,8-dimethyl-3-(2,4,5-trimethoxy-phenyl)-8H-pyrano[2,3-f]chromen-4-on|5-methoxy-8,8-dimethyl-3-(2,4,5-trimethoxy-phenyl)-8H-pyrano[2,3-f]chromen-4-one|5-methoxybarbigerone|toxicarol
(-)-(7R,8R)-4,7,9,8,9-pentahydroxy-3,3,5-trimethoxy-8-O-4-neolignan|3-(4-{[(1R,2R)-1,3-dihydroxy-1-(4-hydroxy-3-methoxyphenyl)propan-2-yl]oxy}-3,5-dimethoxyphenyl)propane-1,2-diol|casearialignan D
2alpha-hydroperoxy-8-O-isobutyryl-9alpha-acetoxycumambrin B|2??-Hydroperoxy-8-O-isobutyryl-9??-acetoxycumambrin B
8alpha-(4-hydroxymethacryloyloxy)-10alpha-hydroxy-1,13-dimethoxy-hirsutinolide
(1R*,4R*,8S*,10R*)-1,4-epoxy-1-ethoxy-8,13-diacetoxy-10-hydroxy-germacra-5E,7(11)-dien-6,12-olide
O1-Me,8-propanoyl,13-Ac-1,4-Epoxy-1,8,10,13-tetrahydroxy-5,7(11)-germacradien-12,6-olide
angeloyl beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranoside|everlastoside F
12-(1,1-dimethylallyl)-5,7,9-trihydroxy-10-methoxy-2,2-dimethyl-2H-pyrano[3,2-b]xanthen-6-one|linixanthone A
C24H24O7_Methyl (2R)-4-hydroxy-2-[4-hydroxy-3-(3-methyl-2-buten-1-yl)benzyl]-3-(4-hydroxyphenyl)-5-oxo-2,5-dihydro-2-furancarboxylate
C21H28O9_1-O-{[(3aS,6Z,10E,11aR)-10-Methyl-3-methylene-2-oxo-2,3,3a,4,5,8,9,11a-octahydrocyclodeca[b]furan-6-yl]carbonyl}-beta-D-glucopyranose
C21H28O9_2-Hydroxycyclohexyl 2-O-[(2E)-3-(4-hydroxyphenyl)-2-propenoyl]-beta-D-glucopyranoside
[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (3aS,6Z,10E,11aR)-10-methyl-3-methylidene-2-oxo-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-6-carboxylate
2-oxapentacyclo[21.2.2.13,7.110,14.015,20]nonacosa-1(25),3,5,7(29),10(28),11,13,15(20),16,18,23,26-dodecaene-4,13,18-triol
CONFIDENCE Predicted
[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (3aS,6Z,10E,11aR)-10-methyl-3-methylidene-2-oxo-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-6-carboxylate_major
[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (3aS,6Z,10E,11aR)-10-methyl-3-methylidene-2-oxo-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-6-carboxylate_7.2\\%
[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (3aS,6Z,10E,11aR)-10-methyl-3-methylidene-2-oxo-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-6-carboxylate_5.5\\%
[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (3aS,6Z,10E,11aR)-10-methyl-3-methylidene-2-oxo-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-6-carboxylate_4.0\\%
Ala Asp Gly Tyr
C18H24N4O8 (424.15940639999997)
Ala Asp Tyr Gly
C18H24N4O8 (424.15940639999997)
Ala Phe Gly Met
C19H28N4O5S (424.17803180000004)
Ala Phe Met Gly
C19H28N4O5S (424.17803180000004)
Ala Gly Asp Tyr
C18H24N4O8 (424.15940639999997)
Ala Gly Phe Met
C19H28N4O5S (424.17803180000004)
Ala Gly Met Phe
C19H28N4O5S (424.17803180000004)
Ala Gly Tyr Asp
C18H24N4O8 (424.15940639999997)
Ala Met Phe Gly
C19H28N4O5S (424.17803180000004)
Ala Met Gly Phe
C19H28N4O5S (424.17803180000004)
Ala Tyr Asp Gly
C18H24N4O8 (424.15940639999997)
Ala Tyr Gly Asp
C18H24N4O8 (424.15940639999997)
Cys Phe Gly Val
C19H28N4O5S (424.17803180000004)
Cys Phe Val Gly
C19H28N4O5S (424.17803180000004)
Cys Gly Phe Val
C19H28N4O5S (424.17803180000004)
Cys Gly Val Phe
C19H28N4O5S (424.17803180000004)
Cys Thr Thr Thr
Cys Val Phe Gly
C19H28N4O5S (424.17803180000004)
Cys Val Gly Phe
C19H28N4O5S (424.17803180000004)
Asp Ala Gly Tyr
C18H24N4O8 (424.15940639999997)
Asp Ala Tyr Gly
C18H24N4O8 (424.15940639999997)
Asp Phe Gly Ser
C18H24N4O8 (424.15940639999997)
Asp Phe Ser Gly
C18H24N4O8 (424.15940639999997)
Asp Gly Ala Tyr
C18H24N4O8 (424.15940639999997)
Asp Gly Phe Ser
C18H24N4O8 (424.15940639999997)
Asp Gly His Pro
C17H24N6O7 (424.17063939999997)
Asp Gly Pro His
C17H24N6O7 (424.17063939999997)
Asp Gly Ser Phe
C18H24N4O8 (424.15940639999997)
Asp Gly Tyr Ala
C18H24N4O8 (424.15940639999997)
Asp His Gly Pro
C17H24N6O7 (424.17063939999997)
Asp His Pro Gly
C17H24N6O7 (424.17063939999997)
Asp Pro Gly His
C17H24N6O7 (424.17063939999997)
Asp Pro His Gly
C17H24N6O7 (424.17063939999997)
Asp Ser Phe Gly
C18H24N4O8 (424.15940639999997)
Asp Ser Gly Phe
C18H24N4O8 (424.15940639999997)
Asp Tyr Ala Gly
C18H24N4O8 (424.15940639999997)
Asp Tyr Gly Ala
C18H24N4O8 (424.15940639999997)
Glu Gly Gly Tyr
C18H24N4O8 (424.15940639999997)
Glu Gly Tyr Gly
C18H24N4O8 (424.15940639999997)
Glu Tyr Gly Gly
C18H24N4O8 (424.15940639999997)
Phe Ala Gly Met
C19H28N4O5S (424.17803180000004)
Phe Ala Met Gly
C19H28N4O5S (424.17803180000004)
Phe Cys Gly Val
C19H28N4O5S (424.17803180000004)
Phe Cys Val Gly
C19H28N4O5S (424.17803180000004)
Phe Asp Gly Ser
C18H24N4O8 (424.15940639999997)
Phe Asp Ser Gly
C18H24N4O8 (424.15940639999997)
Phe Gly Ala Met
C19H28N4O5S (424.17803180000004)
Phe Gly Cys Val
C19H28N4O5S (424.17803180000004)
Phe Gly Asp Ser
C18H24N4O8 (424.15940639999997)
Phe Gly Met Ala
C19H28N4O5S (424.17803180000004)
Phe Gly Ser Asp
C18H24N4O8 (424.15940639999997)
Phe Gly Val Cys
C19H28N4O5S (424.17803180000004)
Phe Met Ala Gly
C19H28N4O5S (424.17803180000004)
Phe Met Gly Ala
C19H28N4O5S (424.17803180000004)
Phe Ser Asp Gly
C18H24N4O8 (424.15940639999997)
Phe Ser Gly Asp
C18H24N4O8 (424.15940639999997)
Phe Val Cys Gly
C19H28N4O5S (424.17803180000004)
Phe Val Gly Cys
C19H28N4O5S (424.17803180000004)
Gly Ala Asp Tyr
C18H24N4O8 (424.15940639999997)
Gly Ala Phe Met
C19H28N4O5S (424.17803180000004)
Gly Ala Met Phe
C19H28N4O5S (424.17803180000004)
Gly Ala Tyr Asp
C18H24N4O8 (424.15940639999997)
Gly Cys Phe Val
C19H28N4O5S (424.17803180000004)
Gly Cys Val Phe
C19H28N4O5S (424.17803180000004)
Gly Asp Ala Tyr
C18H24N4O8 (424.15940639999997)
Gly Asp Phe Ser
C18H24N4O8 (424.15940639999997)
Gly Asp His Pro
C17H24N6O7 (424.17063939999997)
Gly Asp Pro His
C17H24N6O7 (424.17063939999997)
Gly Asp Ser Phe
C18H24N4O8 (424.15940639999997)
Gly Asp Tyr Ala
C18H24N4O8 (424.15940639999997)
Gly Glu Gly Tyr
C18H24N4O8 (424.15940639999997)
Gly Glu Tyr Gly
C18H24N4O8 (424.15940639999997)
Gly Phe Ala Met
C19H28N4O5S (424.17803180000004)
Gly Phe Cys Val
C19H28N4O5S (424.17803180000004)
Gly Phe Asp Ser
C18H24N4O8 (424.15940639999997)
Gly Phe Met Ala
C19H28N4O5S (424.17803180000004)
Gly Phe Ser Asp
C18H24N4O8 (424.15940639999997)
Gly Phe Val Cys
C19H28N4O5S (424.17803180000004)
Gly Gly Glu Tyr
C18H24N4O8 (424.15940639999997)
Gly Gly Tyr Glu
C18H24N4O8 (424.15940639999997)
Gly His Asp Pro
C17H24N6O7 (424.17063939999997)
Gly His Pro Asp
C17H24N6O7 (424.17063939999997)
Gly Met Ala Phe
C19H28N4O5S (424.17803180000004)
Gly Met Phe Ala
C19H28N4O5S (424.17803180000004)
Gly Pro Asp His
C17H24N6O7 (424.17063939999997)
Gly Pro His Asp
C17H24N6O7 (424.17063939999997)
Gly Ser Asp Phe
C18H24N4O8 (424.15940639999997)
Gly Ser Phe Asp
C18H24N4O8 (424.15940639999997)
Gly Val Cys Phe
C19H28N4O5S (424.17803180000004)
Gly Val Phe Cys
C19H28N4O5S (424.17803180000004)
Gly Tyr Ala Asp
C18H24N4O8 (424.15940639999997)
Gly Tyr Asp Ala
C18H24N4O8 (424.15940639999997)
Gly Tyr Glu Gly
C18H24N4O8 (424.15940639999997)
Gly Tyr Gly Glu
C18H24N4O8 (424.15940639999997)
His Asp Gly Pro
C17H24N6O7 (424.17063939999997)
His Asp Pro Gly
C17H24N6O7 (424.17063939999997)
His Gly Asp Pro
C17H24N6O7 (424.17063939999997)
His Gly Pro Asp
C17H24N6O7 (424.17063939999997)
His Pro Asp Gly
C17H24N6O7 (424.17063939999997)
His Pro Gly Asp
C17H24N6O7 (424.17063939999997)
Met Ala Phe Gly
C19H28N4O5S (424.17803180000004)
Met Ala Gly Phe
C19H28N4O5S (424.17803180000004)
Met Phe Ala Gly
C19H28N4O5S (424.17803180000004)
Met Phe Gly Ala
C19H28N4O5S (424.17803180000004)
Met Gly Ala Phe
C19H28N4O5S (424.17803180000004)
Met Gly Phe Ala
C19H28N4O5S (424.17803180000004)
Met Ser Ser Thr
Met Ser Thr Ser
Met Thr Ser Ser
β-D-Glucopyranosiduronic acid, 2-(1H-indol-4-yloxy)-1-[[(1-methylethyl)amino]methyl]ethyl
Pro Asp Gly His
C17H24N6O7 (424.17063939999997)
Pro Asp His Gly
C17H24N6O7 (424.17063939999997)
Pro Gly Asp His
C17H24N6O7 (424.17063939999997)
Pro Gly His Asp
C17H24N6O7 (424.17063939999997)
Pro His Asp Gly
C17H24N6O7 (424.17063939999997)
Pro His Gly Asp
C17H24N6O7 (424.17063939999997)
Ser Asp Phe Gly
C18H24N4O8 (424.15940639999997)
Ser Asp Gly Phe
C18H24N4O8 (424.15940639999997)
Ser Phe Asp Gly
C18H24N4O8 (424.15940639999997)
Ser Phe Gly Asp
C18H24N4O8 (424.15940639999997)
Ser Gly Asp Phe
C18H24N4O8 (424.15940639999997)
Ser Gly Phe Asp
C18H24N4O8 (424.15940639999997)
Ser Met Ser Thr
Ser Met Thr Ser
Ser Ser Met Thr
Ser Ser Thr Met
Ser Thr Met Ser
Ser Thr Ser Met
Thr Cys Thr Thr
Thr Met Ser Ser
Thr Ser Met Ser
Thr Ser Ser Met
Thr Thr Cys Thr
Thr Thr Thr Cys
Val Cys Phe Gly
C19H28N4O5S (424.17803180000004)
Val Cys Gly Phe
C19H28N4O5S (424.17803180000004)
Val Phe Cys Gly
C19H28N4O5S (424.17803180000004)
Val Phe Gly Cys
C19H28N4O5S (424.17803180000004)
Val Gly Cys Phe
C19H28N4O5S (424.17803180000004)
Val Gly Phe Cys
C19H28N4O5S (424.17803180000004)
Tyr Ala Asp Gly
C18H24N4O8 (424.15940639999997)
Tyr Ala Gly Asp
C18H24N4O8 (424.15940639999997)
Tyr Asp Ala Gly
C18H24N4O8 (424.15940639999997)
Tyr Asp Gly Ala
C18H24N4O8 (424.15940639999997)
Tyr Glu Gly Gly
C18H24N4O8 (424.15940639999997)
Tyr Gly Ala Asp
C18H24N4O8 (424.15940639999997)
Tyr Gly Asp Ala
C18H24N4O8 (424.15940639999997)
Tyr Gly Glu Gly
C18H24N4O8 (424.15940639999997)
Tyr Gly Gly Glu
C18H24N4O8 (424.15940639999997)
(+)-5-trans Cloprostenol
C22H29ClO6 (424.16525640000003)
(+)-15-epi Cloprostenol
C22H29ClO6 (424.16525640000003)
Cloprostenol
C22H29ClO6 (424.16525640000003)
D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents D012102 - Reproductive Control Agents > D008186 - Luteolytic Agents
(+)-Cloprostenol
C22H29ClO6 (424.16525640000003)
Taraxinic acid glucosyl ester
2-heptadecyl-4,5-dihydro-1H-imidazole-1-ethanol phosphate
C30H18Li2O2 (424.16268279999997)
3-Thiophenecarboxamide, 2-[(aminocarbonyl)amino]-5-[2-[2-[Methyl(phenylmethyl)amino]ethoxy]phenyl]-
C22H24N4O3S (424.15690340000003)
Ethyl 4-acetoxy-5-(benzyloxy)-7,8-dimethoxy-2-naphthoate
4-[(5-carbamoyl-o-tolyl)azo]-3-hydroxynaphth-2-anilide
C25H20N4O3 (424.15353300000004)
10-[4-(1-naphthalenyl)phenyl]-9-anthracenyl]-Boronic acid[
10-[4-(2-naphthalenyl)phenyl]-9-anthracenyl]-Boronic acid
4-([trans(trans)]-4-butyl-[1,1-bicyclohexyl]-4-yl)-1-iodo-Benzene
[trans(trans)]-1-(4-Butyl[1,1-bicyclohexyl]-4-yl)-4-iodobenzene
[4-[9-(Naphthalen-2-yl)anthracen-10-yl]phenyl]boronic acid
9-Octadecen-1-ol, (Z)-, phosphate, potassium salt
C18H35K2O4P (424.15470000000005)
2-[[4-[(2-cyanoethyl)(2-phenylethyl)amino]phenyl]azo]-5-nitrobenzonitrile
N,N-Diacetylchitobiose
C16H28N2O11 (424.16930179999997)
The N,N-diacetylated derivative of chitobiose, but with no stereodesignation for the anomeric carbon atom. N,N'-Diacetylchitobiose is a dimer of β(1,4) linked N-acetyl-D glucosamine. N,N'-Diacetylchitobiose is the hydrolysate of chitin and can be used as alternative carbon source by?E. coli[1].
Anileridine hydrochloride
C22H30Cl2N2O2 (424.16842199999996)
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent
(3S,4S,5S)-3-amino-4,5-dihydroxy-6-[[(1S)-1-[(3S)-8-hydroxy-1-oxo-3,4-dihydroisochromen-3-yl]-3-methylbutyl]amino]-6-oxohexanoic acid
GlcNAc1-beta-3GalNAc
C16H28N2O11 (424.16930179999997)
Ethyl 2-[2-[2-(4-methoxyanilino)-2-oxoethyl]-1-oxoisoquinolin-5-yl]oxypropanoate
beta-D-GlcpNAc-(1->6)-D-GalpNAc
C16H28N2O11 (424.16930179999997)
An amino disaccharide consisting of N-acetyl-D-galactosamine having a N-acetyl-beta-D-glucosaminyl residue attached at the 6-position.
2-Acetamido-6-O-(2-acetamido-2-deoxy-a-D-galactopyranosyl)-2-deoxy-D-galactopyranose
C16H28N2O11 (424.16930179999997)
2-Acetamido-4-O-(2-acetamido-2-deoxy-a-D-galactopyranosyl)-2-deoxy-D-galactopyranose
C16H28N2O11 (424.16930179999997)
SPIRADOLINE
C22H30Cl2N2O2 (424.16842199999996)
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent D002491 - Central Nervous System Agents > D000700 - Analgesics D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics
Diethyl (1r,2s,3r,4s)-5,6-Bis(4-Hydroxyphenyl)-7-Oxabicyclo[2.2.1]hept-5-Ene-2,3-Dicarboxylate
12-(2-hydroxyethyl)-2-(1-methylethoxy)-13,14-dihydronaphtho[2,1-a]pyrrolo[3,4-c]carbazol-5(12H)-one
C27H24N2O3 (424.17868339999995)
(4,11-Diacetyloxy-10-hydroxy-1,5-dimethylspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2-oxirane]-2-yl)methyl acetate
[(2R,4S,10R,11S)-10,11-diacetyloxy-4-hydroxy-1,5-dimethylspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2-oxirane]-2-yl]methyl acetate
2-(3,4-dichlorophenyl)-N-methyl-N-[7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]decan-8-yl]acetamide
C22H30Cl2N2O2 (424.16842199999996)
beta-D-GalpNAc-(1->4)-beta-D-GlcpNAc
C16H28N2O11 (424.16930179999997)
beta-D-GalpNAc-(1->4)-D-GlcpNAc with beta configuration at the anomeric centre.
beta-D-GlcpNAc-(1->3)-alpha-D-GalpNAc
C16H28N2O11 (424.16930179999997)
An amino disaccharide comprising an N-acetyl-beta-D-glucosamine residue linked (1->3) to an N-acetyl-beta-D-galactosamine residue at the reducing end.
beta-D-GlcpNAc-(1->6)-alpha-D-GalpNAc
C16H28N2O11 (424.16930179999997)
beta-D-GlcpNAc-(1->6)-D-GalpNAc in which the anomeric configuration of the reducing-end GalNAc residue is alpha.
N-[2-(2-ethyl-1-piperidinyl)ethyl]-2-[(2-methyl-1,3-benzothiazol-6-yl)sulfonylamino]acetamide
C19H28N4O3S2 (424.16027379999997)
N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-alpha-D-glucosamine
C16H28N2O11 (424.16930179999997)
Brasixanthone D
A member of the class of pyranoxanthones that is 2H,6H-pyrano[3,2-b]xanthen-6-one substituted by a 2-[(2S)-3,3-dimethyloxiran-2-yl]-2-hydroxyethyl group at position 12, hydroxy groups at positions 5 and 8 and geminal methyl groups at position 2. It is isolated from the stem bark of Calophyllum brasiliense and exhibits significant inhibitory activity against 12-O-tetradecanoylphorbol-13-acetate induced Epstein-Barr virus early antigen activation in Raji cells.
fumicycline A
An anthrafuran and meroterpenoid that is 2,3,11,11a-tetrahydroanthra[2,3-b]furan which is substituted by a 2-oxopropylidene group at position 2, a 3-methylbut-2-en-1-yl group at position 5, an oxo group at position 11, and hydroxy groups at positions 3a, 7, 9, and 10. It is one of the cryptic secondary metabolites (i.e. expressed at very low levels in the absence of specific triggers and/or conditions) of Aspergillus fumogatus, obtained following the induction of the fungus with the actinomycete Streptomyces rapamycinicus.
(5E)-N-[3-(ethylcarbamoyl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]-5-(3-methyl-6-oxocyclohexa-2,4-dien-1-ylidene)-1,2-dihydropyrazole-3-carboxamide
C22H24N4O3S (424.15690340000003)
N-[1-(3-methoxyphenyl)-3-(1-naphthalenylamino)-3-oxopropyl]benzamide
C27H24N2O3 (424.17868339999995)
methyl 3-[[2-[4-(furan-2-carbonyl)piperazin-1-yl]acetyl]amino]-6-methyl-1H-indole-2-carboxylate
7-[[1-(2-oxolanylmethyl)-5-tetrazolyl]-(1-pyrrolidinyl)methyl]-5H-[1,3]dioxolo[4,5-g]quinolin-6-one
beta-D-GalpNAc-(1->3)-beta-D-GlcpNAc
C16H28N2O11 (424.16930179999997)
N-[(E)-(3-hydroxy-4-methoxyphenyl)methylideneamino]-4,6-diphenylpyrimidine-2-carboxamide
C25H20N4O3 (424.15353300000004)
N-[5-ethyl-3-[(4-fluorophenyl)-(4-morpholinyl)methyl]-2-thiophenyl]benzamide
C24H25FN2O2S (424.16206819999996)
2-Acetamido-6-O-(2-acetamido-2-deoxy-beta-D-glucopyranosyl)-2-deoxy-D-glucopyranose
C16H28N2O11 (424.16930179999997)
(2S,4R)-N-[(1S,2S)-2-chloro-1-[(3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)-2-oxanyl]propyl]-1-methyl-4-propyl-2-pyrrolidinecarboxamide
C18H33ClN2O5S (424.17985980000003)
N-acetyl-D-galactosaminyl-(1->3)-N-acetyl-D-galactosamine
C16H28N2O11 (424.16930179999997)
beta-D-GalpNAc-(1->3)-alpha-D-GalpNAc
C16H28N2O11 (424.16930179999997)
An amino disaccharide comprised of N-acetyl-alpha-D-galactosamine having an N-acetyl-D-galactosaminyl residue attached at the 3-position via a beta-linkage.
2-acetamido-4-O-(2-acetamido-2-deoxy-beta-D-galactopyranosyl)-2-deoxy-alpha-D-galactopyranose
C16H28N2O11 (424.16930179999997)
(1S,5R)-7-[4-(3-methoxyphenyl)phenyl]-3-[(1-methyl-4-imidazolyl)sulfonyl]-3,6-diazabicyclo[3.1.1]heptane
C22H24N4O3S (424.15690340000003)
1,3-benzodioxol-5-yl-[(1R,5S)-7-[4-[(E)-2-phenylethenyl]phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]methanone
C27H24N2O3 (424.17868339999995)
N-[(2S,3R,6S)-2-(hydroxymethyl)-6-(2-oxo-2-piperidin-1-ylethyl)-3,6-dihydro-2H-pyran-3-yl]-2-methoxybenzenesulfonamide
C20H28N2O6S (424.16679880000004)
N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-2-methoxybenzenesulfonamide
C20H28N2O6S (424.16679880000004)
N-[(2R,3R,6R)-2-(hydroxymethyl)-6-(2-oxo-2-piperidin-1-ylethyl)-3,6-dihydro-2H-pyran-3-yl]-2-methoxybenzenesulfonamide
C20H28N2O6S (424.16679880000004)
N-[(2R,3S,6S)-6-[2-[(2-chlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-4-oxanecarboxamide
C21H29ClN2O5 (424.17648940000004)
2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-cyclopentylacetamide
C20H28N2O6S (424.16679880000004)
N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-2-methoxybenzenesulfonamide
C20H28N2O6S (424.16679880000004)
N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-2-methoxybenzenesulfonamide
C20H28N2O6S (424.16679880000004)
N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-2-methoxybenzenesulfonamide
C20H28N2O6S (424.16679880000004)
N-[(2S,3R,6S)-6-[2-[(2-chlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)oxan-3-yl]oxane-4-carboxamide
C21H29ClN2O5 (424.17648940000004)
N-[(2S,3R,6R)-6-[2-[(2-chlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)oxan-3-yl]oxane-4-carboxamide
C21H29ClN2O5 (424.17648940000004)
N-[(2S,3S,6S)-6-[2-[(2-chlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-4-oxanecarboxamide
C21H29ClN2O5 (424.17648940000004)
2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-cyclopentylacetamide
C20H28N2O6S (424.16679880000004)
2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-cyclopentylacetamide
C20H28N2O6S (424.16679880000004)
N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-2-methoxybenzenesulfonamide
C20H28N2O6S (424.16679880000004)
N-[(2R,3S,6R)-6-[2-[(2-chlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-4-oxanecarboxamide
C21H29ClN2O5 (424.17648940000004)
N-[(2R,3R,6R)-6-[2-[(2-chlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-4-oxanecarboxamide
C21H29ClN2O5 (424.17648940000004)
N-[(2R,3S,6R)-6-[2-(4-cyclopropyl-1-triazolyl)ethyl]-2-(hydroxymethyl)-3-oxanyl]-4-fluorobenzenesulfonamide
C19H25FN4O4S (424.15804620000006)
N-[(2S,3S,6R)-6-[2-(4-cyclopropyl-1-triazolyl)ethyl]-2-(hydroxymethyl)-3-oxanyl]-4-fluorobenzenesulfonamide
C19H25FN4O4S (424.15804620000006)
N-[(2R,3S,6S)-6-[2-(4-cyclopropyl-1-triazolyl)ethyl]-2-(hydroxymethyl)-3-oxanyl]-4-fluorobenzenesulfonamide
C19H25FN4O4S (424.15804620000006)
2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-cyclopentylacetamide
C20H28N2O6S (424.16679880000004)
2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-cyclopentylacetamide
C20H28N2O6S (424.16679880000004)
[(1S,2aR,8bR)-4-[(3-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-(4-oxanyl)methanone
[(1R,2aR,8bR)-4-[(3-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-(4-oxanyl)methanone
[(3aS,4S,9bS)-1-(benzenesulfonyl)-5-methyl-8-pent-1-ynyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-4-yl]methanol
C24H28N2O3S (424.18205380000006)
N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-2-methoxybenzenesulfonamide
C20H28N2O6S (424.16679880000004)
N-[(2S,3S,6R)-6-[2-[(2-chlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-4-oxanecarboxamide
C21H29ClN2O5 (424.17648940000004)
N-[(2R,3R,6S)-6-[2-[(2-chlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-4-oxanecarboxamide
C21H29ClN2O5 (424.17648940000004)
N-[(2S,3R,6S)-6-[2-(4-cyclopropyl-1-triazolyl)ethyl]-2-(hydroxymethyl)-3-oxanyl]-4-fluorobenzenesulfonamide
C19H25FN4O4S (424.15804620000006)
N-[(2R,3R,6R)-6-[2-(4-cyclopropyl-1-triazolyl)ethyl]-2-(hydroxymethyl)-3-oxanyl]-4-fluorobenzenesulfonamide
C19H25FN4O4S (424.15804620000006)
N-[(2S,3R,6R)-6-[2-(4-cyclopropyl-1-triazolyl)ethyl]-2-(hydroxymethyl)-3-oxanyl]-4-fluorobenzenesulfonamide
C19H25FN4O4S (424.15804620000006)
N-[(2S,3S,6S)-6-[2-(4-cyclopropyl-1-triazolyl)ethyl]-2-(hydroxymethyl)-3-oxanyl]-4-fluorobenzenesulfonamide
C19H25FN4O4S (424.15804620000006)
N-[(2R,3R,6S)-6-[2-(4-cyclopropyl-1-triazolyl)ethyl]-2-(hydroxymethyl)-3-oxanyl]-4-fluorobenzenesulfonamide
C19H25FN4O4S (424.15804620000006)
2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-cyclopentylacetamide
C20H28N2O6S (424.16679880000004)
2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-cyclopentylacetamide
C20H28N2O6S (424.16679880000004)
2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-cyclopentylacetamide
C20H28N2O6S (424.16679880000004)
[(1S,2aS,8bS)-4-[(3-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-(4-oxanyl)methanone
[(1R,2aS,8bS)-4-[(3-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-(4-oxanyl)methanone
2-acetamido-2-deoxy-D-gluco-hexopyranosyl-(1->3)-2-acetamido-2-deoxy-alpha-D-galacto-hexopyranose
C16H28N2O11 (424.16930179999997)
[2-butyl-5-chloro-3-[[4-[2-(2,3-dihydro-1H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol
N-[(Z)-(2-hydroxy-3-methoxyphenyl)methylideneamino]-4,6-diphenylpyrimidine-2-carboxamide
C25H20N4O3 (424.15353300000004)
(3alpha)-3-Hydroxy-12,13-epoxytrichothec-9-ene-4,8,15-triyl triacetate
3-Hydroxy-12,13-epoxytrichothec-9-ene-4,8,15-triyl triacetate
[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (3aS,10Z,11aR)-10-methyl-3-methylidene-2-oxo-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-6-carboxylate
(2S,4R)-N-[(1R)-2-chloro-1-[(2R,3R,4S,5R,6S)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide
C18H33ClN2O5S (424.17985980000003)
platencin(1-)
C24H26NO6 (424.17600360000006)
A monocarboxylic acid anion that is the conjugate base of platencin resulting from the deprotonation of the carboxy group; major species at pH 7.3.
Cleocin
C18H33ClN2O5S (424.17985980000003)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D055231 - Lincosamides D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors
beta-D-GalpNAc-(1->4)-D-GlcpNAc
C16H28N2O11 (424.16930179999997)
An amino disaccharide consisting of N-acetylglucosamine having an N-acetylgalactosaminyl resiude attached at the 4-position via a beta-linkage.
N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-aldehydo-D-glucosamine
C16H28N2O11 (424.16930179999997)
alpha-D-GalpNAc-(1->4)-beta-D-GlcpNAc
C16H28N2O11 (424.16930179999997)
An alpha-D-GalpNAc-(1->4)-D-GlcpNAc in which the reducing end anomeric centre has beta-configuration.
D-GalpNAc-(1->3)-D-GalpNAc
C16H28N2O11 (424.16930179999997)
A disaccharide composed of two 2-(acetylamino)-2-deoxy-D-galactopyranose units in (1->3) linkage.
2-Acetamido-2-deoxy-3-O-(2-acetamido-2-deoxy-B-D-glucopyranosyl)-D-galactopyranose
C16H28N2O11 (424.16930179999997)
beta-D-GalpNAc-(1->4)-alpha-D-GalpNAc
C16H28N2O11 (424.16930179999997)
An amino disaccharide comprised of N-acetyl-alpha-D-galactosamine having an N-acetyl-D-galactosaminyl residue attached at the 4-position via a beta-linkage. Important epitope forming part of the O-polysaccharides of some Gram-negative bacteria.
alpha-D-GalpNAc-(1->3)-D-GalpNAc
C16H28N2O11 (424.16930179999997)
An amino disaccharide consisting of two N-acetyl-D-galactosamine units joined via an alpha-(1->3)-linkage.
alpha-D-GalpNAc-(1->4)-D-GlcpNAc
C16H28N2O11 (424.16930179999997)
An amino disaccharide consisting of N-acetyl-D-glucosamine having an N-acetyl-alpha-D-galactosminyl resiude attached at the 4-position.
alpha-D-GalNpAc-(1->3)-beta-D-GalpNAc
C16H28N2O11 (424.16930179999997)
An alpha-D-GalpNAc-(1->3)-D-GalpNAc having beta-configuration at the reducing end anomeric centre.
clindamycin
C18H33ClN2O5S (424.17985980000003)
A carbohydrate-containing antibiotic that is the semisynthetic derivative of lincomycin, a natural antibiotic.
N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-beta-D-glucosamine
C16H28N2O11 (424.16930179999997)
An N,N-diacetylchitobiose having beta-configuration at the reducing end anomeric centre.
RBC8
C25H20N4O3 (424.15353300000004)
RBC8 is a novel small molecule inhibitor of Ral GTPase; has IC50 of 3.5 μM in H2122 cell and 3.4 μM in H358 cell. IC50 value: Target: Ral GTPase inhibitor RBC8 or BQU57 treatment showed no further inhibition of colony formation after Ral knockdown. RBC8 and BQU57 showed favorable properties that define good drug candidates. To test the effect of Ral inhibitors on xenograft tumor growth, nude mice were inoculated subcutaneously with H2122 human lung cancer cells and treated intraperitoneally with 50 mg/kg/d of RBC8 for 21 days (except weekends). RBC8 inhibited tumor growth to a similar extent as dual knockdown of RalA and RalB.